life scienc diagnost tool
uniqu posit advanc precis ashg
adjust quarterli ep estim
attend tmo exhibitor educ event work togeth
advanc precis medicin innov yesterday american societi
human genet ashg annual meet octob san diego
believ escal invest precis medicin global
exhibit key secular growth driver given breadth tool
capabl compani offer genom proteom
molecular tissue-level analysi sampl storag data analysi etc
across academ biopharma clinic end market also tmo
activ capit opportun establish
precis medicin scienc center global addit case studi
biopharma diagnost compani use tmo tool advanc
precis medicin particularli noteworthi us yesterday
present tmo involv larg scale popul genom
project saudi genom project project involv
subject address preval rare recess disord tmo
custom tool cost effect use develop diagnost
screen better manag prevent larg group inherit diseas
saudi arabia also announc week custom microarray
technolog use next phase finngen precis
medicin project one largest longitudin studi aim
analyz genet data combin nation health record involv
individu separ note adjust
quarterli ep pace full year ep est valuat
affect better reflect continu om dilut
patheon acquisit favor y/i comparison vs
ep impact hurrican tax reform-rel bonu payment
model updat revis ep estim y/i vs
prior revis ep estim y/i
vs prior quarterli full year revenu full year
ep estim unchang
valuat pt base price-to-earnings
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
exhibit select govern invest precis medicin
countri version precis medicin initi
fiscal year end dec million except per share scienc diagnost product revenu profit profit develop expens incom non-oper non-oper expens incom tax incom incom analysiscost revenu margin gener administr develop margin tax margin growthlif scienc diagnost product bpssg incom bpsnet incom compani report btig estim
btig cover compani mention report
appendix analyst certif import disclosur
